Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 3Terminated 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 8Neoplasm Metastasis 7Multiple Myeloma 6Prostatic Neoplasms 5Pain 3Uterine Cervical Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Bone Neoplasms 2Uterine Cervical Dysplasia 1Urologic Neoplasms 1Small Cell Lung Carcinoma 1Precancerous Conditions 1Pleural Effusion, Malignant 1Osteoporosis 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm, Residual 1Lung Neoplasms 1Kidney Neoplasms 1Humoral Hypercalcemia Of Malignancy 1Hematologic Neoplasms 1Giant Cell Tumors of Bone 1Giant Cell Tumor of Bone 1Disease Progression 1Carcinoma, Ductal, Breast 1Breast Neoplasms, Male 1Bone Diseases, Metabolic 1Adenocarcinoma 1

Interventions

Sunitinib 27Nivolumab 26pembrolizumab 23Sorafenib 17Everolimus 14Cyclophosphamide 13Interleukin-2 10Bevacizumab 10Radiosurgery 9spartalizumab 8pazopanib 7atezolizumab 7Ipilimumab 7Axitinib 7fludarabine 6aldesleukin 6cabozantinib 5Radiotherapy 5Magnetic Resonance Spectroscopy 5Immunohistochemistry 5Gemcitabine 5peginterferon alfa-2b 4avelumab 4Nephrectomy 4Irinotecan 4Introns 4Gene Expression Profiling 4Capecitabine 4lenvatinib 3fludarabine phosphate 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Carcinoma, Renal Cell × Zoledronic Acid × Clear all
NCT03408652 2021-10-22

MOSCAR

Centre Leon Berard

Phase 3 Terminated
1 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT00582790 2019-11-25

Study of IL2 in Combination With Zoledronic Acid in Patients With Kidney Cancer

University of Wisconsin, Madison

Phase 2 Terminated
12 enrolled 8 charts
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡